Intradermal injection

Source: Wikipedia, the free encyclopedia.
Intradermal injection
A medical professional performs an intradermal (ID) injection
MeSHD007271

Intradermal injection (also intracutaneous or intradermic, abbreviated as ID) is a shallow or superficial

which?
]

Vaccine dose sparing

For vaccination many clinical studies have proven efficacy of ID administration over subcutaneous (SC), intramuscular (IM) or other routes of administration. Since the COVID19 pandemic (2020) EMA and FDA promote the use of ID route of administration in case of possible vaccine shortage, for example during the Monkeypox outbreak in 2022 where 1/5th intradermal (fractional) dosing was advised, due to a risk of vaccine shortage.

Injection sites

Common injection sites include the inner surface of the forearm, the upper back, deltoid, thigh, and under the shoulder blade.[1] Injections sites are often chosen for skin thickness, preferring thicker skin.

Equipment

Equipment include

milliliter. The dosage given is usually less than 0.5 mL, less than given subcutaneously or intramuscularly. A 14-to-12-inch-long (6 to 13 mm) and 26 or 27 gauge thick needle is used.[1]

Mantoux procedure

Mantoux intradermal injection
Intradermal needle insertion angle compared with other injection types.

The traditional procedure of ID injection known as the Mantoux procedure (as used in the

wheal or blister
to appear.

Intradermic needles

Traditionally hypodermic needles are used for intradermal injections, instead of intradermic needles. Various microneedle technology researchers worldwide develop new devices and therapies to overcome typical usability issues associated with the traditional Mantoux procedure. Most intradermic needles require a change in injection technique or instruction to use, for example a perpendicular intradermal injection.[4]

Immune reaction tests sometimes use a set of non-hollow needles for scarification, shallowly abrading the skin. The inoculation is limited to the dermis.

See also

References

  1. ^ .
  2. .
  3. ^ "JYNNEOS Vaccine". Centers for Disease Control and Prevention. 2022-10-21. Retrieved 2022-10-23.
  4. PMID 23680534
    .